annual EBIT:
-$176.10M-$149.04M(-550.78%)Summary
- As of today (September 18, 2025), CDTX annual earnings before interest & taxes is -$176.10 million, with the most recent change of -$149.04 million (-550.78%) on December 31, 2024.
- During the last 3 years, CDTX annual EBIT has fallen by -$133.85 million (-316.76%).
- CDTX annual EBIT is now -16175.60% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$27.38M-$2.12M(-8.37%)Summary
- As of today (September 18, 2025), CDTX quarterly earnings before interest & taxes is -$27.38 million, with the most recent change of -$2.12 million (-8.37%) on June 30, 2025.
- Over the past year, CDTX quarterly EBIT has dropped by -$16.28 million (-146.68%).
- CDTX quarterly EBIT is now -283.50% below its all-time high of $14.92 million, reached on September 30, 2022.
Performance
CDTX quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$124.23M-$16.28M(-15.08%)Summary
- As of today (September 18, 2025), CDTX TTM earnings before interest & taxes is -$124.23 million, with the most recent change of -$16.28 million (-15.08%) on June 30, 2025.
- Over the past year, CDTX TTM EBIT has dropped by -$91.42 million (-278.61%).
- CDTX TTM EBIT is now -22123.43% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CDTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -550.8% | -146.7% | -278.6% |
| 3 y3 years | -316.8% | -108.8% | -87.7% |
| 5 y5 years | -322.1% | -50.4% | -183.5% |
CDTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -550.8% | at low | -283.5% | +49.5% | -1937.9% | at low |
| 5 y | 5-year | -550.8% | at low | -283.5% | +49.5% | -1937.9% | at low |
| alltime | all time | <-9999.0% | at low | -283.5% | +49.5% | <-9999.0% | at low |
CDTX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$27.38M(+8.4%) | -$124.23M(+15.1%) |
| Mar 2025 | - | -$25.27M(-53.4%) | -$107.95M(+18.3%) |
| Dec 2024 | -$176.10M(+550.8%) | -$54.18M(+211.5%) | -$91.22M(+99.4%) |
| Sep 2024 | - | -$17.39M(+56.7%) | -$45.74M(+39.4%) |
| Jun 2024 | - | -$11.10M(+30.0%) | -$32.81M(+15.3%) |
| Mar 2024 | - | -$8.54M(-1.8%) | -$28.46M(+66.1%) |
| Dec 2023 | -$27.06M(-19.2%) | -$8.70M(+94.7%) | -$17.14M(-32.8%) |
| Sep 2023 | - | -$4.47M(-33.8%) | -$25.49M(+318.1%) |
| Jun 2023 | - | -$6.75M(-342.6%) | -$6.10M(-51.1%) |
| Mar 2023 | - | $2.78M(-116.3%) | -$12.46M(-62.8%) |
| Dec 2022 | -$33.50M(-20.7%) | -$17.05M(-214.3%) | -$33.50M(+0.8%) |
| Sep 2022 | - | $14.92M(-213.8%) | -$33.22M(-49.8%) |
| Jun 2022 | - | -$13.11M(-28.2%) | -$66.18M(+56.5%) |
| Mar 2022 | - | -$18.26M(+8.9%) | -$42.29M(+0.1%) |
| Dec 2021 | -$42.26M(-41.2%) | -$16.77M(-7.0%) | -$42.26M(-10.2%) |
| Sep 2021 | - | -$18.04M(-267.4%) | -$47.03M(+1.1%) |
| Jun 2021 | - | $10.77M(-159.1%) | -$46.53M(-38.4%) |
| Mar 2021 | - | -$18.22M(-15.4%) | -$75.51M(+5.1%) |
| Dec 2020 | -$71.85M(+72.2%) | -$21.55M(+22.9%) | -$71.85M(+11.6%) |
| Sep 2020 | - | -$17.53M(-3.7%) | -$64.38M(+46.9%) |
| Jun 2020 | - | -$18.21M(+25.1%) | -$43.82M(+9.9%) |
| Mar 2020 | - | -$14.56M(+3.4%) | -$39.88M(-4.4%) |
| Dec 2019 | -$41.72M | -$14.08M(-565.0%) | -$41.72M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.03M(-121.2%) | -$44.24M(-28.6%) |
| Jun 2019 | - | -$14.27M(-13.0%) | -$61.99M(-1.4%) |
| Mar 2019 | - | -$16.40M(-1.2%) | -$62.88M(-0.6%) |
| Dec 2018 | -$63.28M(+13.6%) | -$16.60M(+12.7%) | -$63.28M(+5.2%) |
| Sep 2018 | - | -$14.72M(-2.8%) | -$60.15M(+4.3%) |
| Jun 2018 | - | -$15.15M(-9.9%) | -$57.67M(-2.5%) |
| Mar 2018 | - | -$16.81M(+24.9%) | -$59.13M(+6.1%) |
| Dec 2017 | -$55.72M(+15.0%) | -$13.46M(+9.9%) | -$55.72M(-1.6%) |
| Sep 2017 | - | -$12.25M(-26.3%) | -$56.62M(-0.2%) |
| Jun 2017 | - | -$16.61M(+24.0%) | -$56.70M(+9.1%) |
| Mar 2017 | - | -$13.40M(-6.7%) | -$51.95M(+7.3%) |
| Dec 2016 | -$48.44M(+49.9%) | -$14.35M(+16.4%) | -$48.44M(+10.1%) |
| Sep 2016 | - | -$12.34M(+4.0%) | -$44.01M(+7.7%) |
| Jun 2016 | - | -$11.86M(+20.0%) | -$40.88M(+15.3%) |
| Mar 2016 | - | -$9.88M(-0.4%) | -$35.47M(+9.8%) |
| Dec 2015 | -$32.31M(+222.6%) | -$9.93M(+7.8%) | -$32.31M(+19.5%) |
| Sep 2015 | - | -$9.21M(+42.8%) | -$27.03M(+27.8%) |
| Jun 2015 | - | -$6.45M(-4.2%) | -$21.15M(+30.6%) |
| Mar 2015 | - | -$6.73M(+44.8%) | -$16.19M(+61.6%) |
| Dec 2014 | -$10.02M(+825.7%) | -$4.65M(+40.0%) | -$10.02M(+86.6%) |
| Sep 2014 | - | -$3.32M(+123.1%) | -$5.37M(+162.2%) |
| Jun 2014 | - | -$1.49M(+166.2%) | -$2.05M(+266.2%) |
| Mar 2014 | - | -$559.00K | -$559.00K |
| Dec 2013 | -$1.08M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual EBIT year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Cidara Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM EBIT year-on-year change?
What is Cidara Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of CDTX is -$176.10M
What is the all time high annual EBIT for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$1.08M
What is Cidara Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, CDTX annual earnings before interest & taxes has changed by -$149.04M (-550.78%)
What is Cidara Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of CDTX is -$27.38M
What is the all time high quarterly EBIT for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $14.92M
What is Cidara Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, CDTX quarterly earnings before interest & taxes has changed by -$16.28M (-146.68%)
What is Cidara Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of CDTX is -$124.23M
What is the all time high TTM EBIT for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$559.00K
What is Cidara Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, CDTX TTM earnings before interest & taxes has changed by -$91.42M (-278.61%)